Cassava Sciences EPS Diluted from Other Gain/Loss (Quarterly) Analysis

Cassava Sciences, Inc. (SAVA)

2.93 -0.22 (-6.98%) USD | NASDAQ | Dec 12, 16:00

2.98 +0.05 (+1.71%) After-Hours: 17:08

View EPS Diluted from Other Gain/Loss (Quarterly) for SAVA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Other Gain/Loss (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

Start Trial

Biogen, Inc.	--
Geron Corp.	--
Ovid Therapeutics, Inc.	--
NovaBay Pharmaceuticals, Inc.	--
Palatin Technologies, Inc.	--